Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience

Table 4 Orthotopic heart transplantation in patients with amyloidosis

Ref.	n	AHSCT	Outcomes
Current series	23	13	1-yr OS 77%
			5-yr OS 43%
MGH[10]	18	14	5-yr OS 60%
United Kingdom 2004[19]	171	3	1-yr 59%
			5-yr approximately 37%
United Kingdom 2010[17]	141	8	1-yr OS 86%
			5-yr OS 45%
Spanish registry[28]	13	3	1-yr OS 43%
			5-yr OS 36%
German group[29]	12	5	1-yr OS 83%
			3-yr OS 83%
ISHLT Registry[8,30]	102	None	1-yr 88%
			4-yr 38%
Maurer[16]	10	8	1-yr 90%
Stanford[20]	9	5	1-yr 100%
French registry[31]	8	3	1-yr 89%

¹Unclear how much overlap between these two groups. Intervals for Dubrey series was 1982-2002 and for Sattianayagam series, interval was 1984-2004, but there was no reference of which patients had been previously reported;

²At least 8 were AL; unclear what other 2 were. ISHT: International Society for Heart Transplant; OS: Overall survival; AHSCT: Autologous hematopoietic stem cell transplantation.